Consistently, no significant differences in tumor histology, proliferation, and apoptosis markers were visible between PyMT;Smyd2 and PyMT tumors at 6 and 12 weeks (Supplementary Fig. S1h–j). Here, SMYD2 is linked to neoplasm.